Keyuan Pharma participated in the formulation of the "Guidelines for the Construction of Digital Transformation of Pharmaceutical Enterprises" to help pharmaceutical enterprises to transform and upgrade digitally!
It is reported that the group standard T/UNP178-2024 "Guidelines for the Construction of Digital Transformation of Pharmaceutical Enterprises" of the China Association for Promoting UN Procurement will be officially implemented on November 23, and the biopharmaceutical industry will usher in important guidance and basis for digital transformation. Shandong Keyuan Pharmaceutical Co., Ltd. (stock code: 301281.SZ), as one of the important drafting units, contributed valuable experience and wisdom to the formulation of this standard.
The "Guidelines for the Construction of Digital Transformation of Pharmaceutical Enterprises" covers transformation planning, resource support, operation implementation, evaluation and inspection, and improvement, etc. It aims to help enterprises establish a scientific digital transformation system, realize the reconstruction and optimization of business processes, and enhance the core competitiveness and market response speed of enterprises.
In the process of formulating this standard, Keyuan Pharma combined own practical experience and put forward many valuable opinions and suggestions. These opinions and suggestions were finally adopted and integrated into the standard, providing important reference and basis for the digital transformation of pharmaceutical enterprises.
As a leading enterprise in the domestic chemical API segment, Keyuan Pharma has always been committed to technological innovation and industrial upgrading, with the goal of high-quality development. In the tide of digital medicine transformation, Keyuan Pharma, with its high industry sensitivity and innovation ability, actively responded to national policies and implemented a number of measures to accelerate the digitalization and intelligent transformation and upgrading of enterprises.
1. Build a digital factory and lay out new quality intelligent manufacturing
Keyuan Pharma fully implements the development strategy of "digitalization of manufacturing", accelerates the deep integration of new generation information technology and manufacturing, builds new quality productivity, focuses on digitalization, intelligence and networking of manufacturing, and promotes the leapfrog transformation from "manufacturing" to "intelligent manufacturing". The digital manufacturing project of injections under construction by the subsidiary Linuo Pharma is built with reference to the "Level 4 Standard of Intelligent Manufacturing", creating benchmark innovation cases in digital manufacturing, smart quality inspection, smart parks, etc., and has the conditions for applying for a lighthouse factory.
After the project is completed and put into production, it will form a situation with Jinan Data Computing Center as the core, distributed storage in Shanghe and Jinan, and off-site secure backup. At the same time, it will connect with Beijing Nuokangda and other pharmaceutical R&D databases and Hainan GSP company marketing databases to achieve a favorable situation of multi-site interconnection and coordinated development.
In 2024, the injection digital manufacturing project has been successfully selected into the list of "2024 Provincial Green, Low-Carbon and High-Quality Development Key Projects", demonstrating the outstanding achievements of Keyuan Pharma & Linuo Pharma in the field of digital manufacturing.
2. Implement lean digital and intelligent operation management, promote quality improvement, cost reduction and efficiency improvement.
Under the background of rapid development of digital and intelligent manufacturing, lean digitalization is a deep integration of lean management and digital technology. The two empower each other and help manufacturing companies optimize resource allocation, improve production efficiency, improve operating efficiency, and improve customer experience. , receiving more and more attention in enterprise development.
In order to achieve high-quality development of the enterprise, Keyuan Pharma lists lean digital and intelligent operation management as one of the core concepts of enterprise development, and takes lean, standardization, automation, informatization, digitalization, intelligence, and green as strategic development path , comprehensively improve production, operation and management capabilities.
Under the guidance of the group's lean experts, Keyuan Pharma established a lean promotion committee, conducted in-depth exploration and practice in building a lean production system, actively introduced advanced tools such as digital and intelligent lean value stream analysis, and started to focus on subject improvement, established a standardized site and achieved significant improvements in the benchmark factory, taking solid steps towards improving the quality, reducing costs and increasing efficiency of the enterprise.
3. Won multiple awards, demonstrating the achievements of digital and intelligent transformation
As a high-tech new chemical enterprise, Keyuan Pharma has always been committed to technological innovation and industrial upgrading, and actively responds to Chinese call to promote intelligent manufacturing and digital transformation, takes smart factories, digital workshops, and unmanned production lines as its development direction, and continuously standardizes operations, improves data to implement the concept of digital intelligence transformation and upgrading.
With outstanding innovation capabilities, significant achievements in digital intelligent transformation, as well as the optimized allocation and efficient use of data resources, Keyuan Pharma has been honored to be listed on the list of "2024 Shandong Chemical Industry Intelligent Transformation Benchmark Enterprises"! Subsidiary Linuo Pharma was selected into the list of "Shandong Province DCMM Standard Implementation Pilot Enterprises in 2024"!
By participating in the formulation of the "Guidelines for Digital Transformation Construction of Pharmaceutical Enterprises", Keyuan Pharma not only provided valuable experience and basis for the industry, but also laid a solid foundation for its own sustainable development. In the future, Keyuan Pharma will continue to move forward on the road of digital transformation and contribute more wisdom and strength to the transformation, upgrading and high-quality development of the pharmaceutical industry.
